Senior insider sale
EVP, Head of North America at RHYTHM PHARMACEUTICALS, INC. — senior position signals high conviction
$8.92M
75.83K shares
What this filing means
LEE JENNIFER KAYDEN plans to sell 75.83K shares of RHYTHM PHARMACEUTICALS, INC. valued at approximately $8.92M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/13/2026ACC: 0001950047-26-008093
Officer· EVP, Head of North America
Since Nov 2020
75.83K
Shares to sell
$8.92M
Approx. market value
75.83K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
8/13/2026
56.60KRestricted Stock Units
N/A
2/11/2024
19.23KTotal acquired75.83K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/13/2026 | Exercise of Stock Options Cash | 56.60K | — |
2/11/2024 | Restricted Stock Units N/A | 19.23K | — |
| Total | 75.83K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
75.83K
Market value
$8.92M
8/13/2026
Total
Units
75.83K
Value
$8.92M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/13/2026 | 75.83K | $8.92M | NASDAQ | Planned |
| Total | 75.83K | $8.92M | ||